Smith Chas P & Associates Pa Cpas Abb Vie Inc. Transaction History

Smith Chas P & Associates Pa Cpas

$1.77 Billion
Q3 2024

A detailed history of Smith Chas P & Associates Pa Cpas transactions in Abb Vie Inc. stock. As of the latest transaction made, Smith Chas P & Associates Pa Cpas holds 4,593 shares of ABBV stock, worth $770,521. This represents 0.05% of its overall portfolio holdings.

Number of Shares

4,593

Previous 4,457 3.05%

Holding current value

$770,521

Previous $764,000 18.72%

% of portfolio

0.05%

Previous 0.05%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	BUY	$163.84 - $199.33 $22,282 - $27,108	136 Added 3.05%	4,593 $907,000
Q2 2024 Jul 29, 2024	SELL	$154.79 - $180.76 $3,560 - $4,157	-23 Reduced 0.51%	4,457 $764,000
Q1 2024 Apr 25, 2024	BUY	$159.82 - $182.1 $160,299 - $182,646	1,003 Added 28.85%	4,480 $815,000
Q4 2023 Feb 01, 2024	BUY	$137.6 - $154.97 $3,990 - $4,494	29 Added 0.84%	3,477 $539,000
Q3 2023 Nov 02, 2023	SELL	$133.59 - $154.65 $244,870 - $283,473	-1,833 Reduced 34.71%	3,448 $514,000
Q2 2023 Jul 31, 2023	BUY	$132.51 - $164.9 $88,781 - $110,483	670 Added 14.53%	5,281 $712,000
Q1 2023 Apr 27, 2023	SELL	$144.61 - $166.54 $19,233 - $22,149	-133 Reduced 2.8%	4,611 $735,000
Q4 2022 Jan 12, 2023	SELL	$138.31 - $165.87 $42,461 - $50,922	-307 Reduced 6.08%	4,744 $767,000
Q3 2022 Nov 22, 2022	SELL	$134.21 - $153.93 $5,368 - $6,157	-40 Reduced 0.79%	5,051 $678,000
Q2 2022 Jul 15, 2022	SELL	$137.62 - $174.96 $130,326 - $165,687	-947 Reduced 15.68%	5,091 $780,000
Q1 2022 May 12, 2022	BUY	$131.98 - $163.75 $395 - $491	3 Added 0.05%	6,038 $979,000
Q4 2021 Feb 07, 2022	BUY	$107.43 - $135.93 $28,039 - $35,477	261 Added 4.52%	6,035 $817,000
Q3 2021 Oct 12, 2021	SELL	$106.4 - $120.78 $21,280 - $24,156	-200 Reduced 3.35%	5,774 $623,000
Q2 2021 Jul 23, 2021	BUY	$105.21 - $117.21 $30,616 - $34,108	291 Added 5.12%	5,974 $673,000
Q4 2020 Feb 10, 2021	BUY	$80.49 - $108.67 $1,529 - $2,064	19 Added 0.34%	5,683 $609,000
Q3 2020 Nov 10, 2020	SELL	$85.91 - $100.83 $37,456 - $43,961	-436 Reduced 7.15%	5,664 $496,000
Q2 2020 Aug 13, 2020	SELL	$73.37 - $98.18 $28,834 - $38,584	-393 Reduced 6.05%	6,100 $599,000
Q1 2020 May 11, 2020	BUY	$64.5 - $97.79 $114,358 - $173,381	1,773 Added 37.56%	6,493 $495,000
Q4 2019 Feb 04, 2020	SELL	$72.13 - $90.25 $7,213 - $9,025	-100 Reduced 2.07%	4,720 $418,000
Q3 2019 Nov 06, 2019	BUY	$62.98 - $75.72 $11,714 - $14,083	186 Added 4.01%	4,820 $365,000
Q2 2019 Aug 09, 2019	BUY	$65.7 - $83.98 $19,907 - $25,445	303 Added 7.0%	4,634 $337,000
Q1 2019 May 08, 2019	SELL	$77.14 - $90.79 $7,714 - $9,079	-100 Reduced 2.26%	4,331 $349,000
Q4 2018 Feb 07, 2019	BUY	$77.85 - $96.01 $145,345 - $179,250	1,867 Added 72.82%	4,431 $408,000
Q3 2018 Nov 09, 2018	BUY	$88.91 - $98.84 $227,965 - $253,425	2,564 New	2,564 $243,000

Others Institutions Holding ABBV

# of Institutions

3,846

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $297B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith Chas P & Associates Pa Cpas, based on Form 13F filings with the SEC.

News

Stay updated on Smith Chas P & Associates Pa Cpas with notifications on news.

Account

Smith Chas P & Associates Pa Cpas Abb Vie Inc. Transaction History